Clinical Trial Update: Doxorubicin and Cyclophosphamide in Treating Older Women With Stage I, Stage II, or Stage III Breast Cancer That Has Been Removed By Surgery [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating doxorubicin and cyclophosphamide in older women with surgically removed Stage I-III breast cancer; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Adriamycin (doxorubicin)
• Cytoxan (cyclophosphamide)

Snippet

Sponsor: UNICANCER | Conditions: Breast Cancer, Cognitive/Functional Effects | Phase 2 | Status: COMPLETED